Filling the need for trusted information on national health issues…

Drug Resistance

  • Your Selections:

Refine Results

date

Tags

Global Community Should Invest In Addressing Antibiotic Resistance

The Guardian: Antibiotic resistance is not theoretical: the threat is real and immediate Mandeep Dhaliwal, director of health and HIV at the United Nations Development Programme (UNDP) “…[W]ith coordinated action between government, industry, civil society, and the public at the international, national, and local levels, we can still turn the…

Continued Funding, Research Required To Address Threat Of Antibiotic Resistance

New York Times: We’re Losing the Race Against Antibiotic Resistance, but There’s Also Reason for Hope Aaron E. Carroll, professor of pediatrics at Indiana University School of Medicine “…We aren’t keeping pace with [antibiotic drug] resistance. … [But there] are … glimmers of good news. … Only in the last…

CSIS Report Examines U.S., Global Prioritization Of Antimicrobial Resistance

Center for Strategic & International Studies: Combating Antimicrobial Resistance in 2015 This report by Audrey Jackson, senior fellow with the CSIS Global Health Policy Center, examines U.S. and global prioritization of antimicrobial resistance. The summary states, “Despite recent progress, however, the United States still needs to formulate and articulate an…

Resilient Partnerships Critical To End Malaria In Southeast Asia

Huffington Post: A Partnership to End Malaria in the Mekong Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria “…The Global Fund partnership is backing a smart regional initiative with a US$100 million grant to tackle artemisinin resistance in Myanmar, Thailand, Viet Nam, Laos, and…

Stop TB Partnership, Pharmaceutical Company Announce New Initiative To Help Developing Countries Access Drug For MDR-TB

Stop TB Partnership: Stop TB Partnership’s Global Drug Facility jumpstarts access to new drugs for multidrug-resistant tuberculosis with innovative public-private partnerships “A new initiative to enable developing countries to access delamanid — one of two new life-saving drugs approved to combat multidrug-resistant (MDR) tuberculosis (TB) — [was on Wednesday] announced…

New Issue Of ‘Global Fund News Flash’ Available Online

Global Fund to Fight AIDS, Tuberculosis and Malaria: Global Fund News Flash The latest issue of the Global Fund News Flash includes an article on the impact of the Global Fund’s investments in the Indo-Pacific region and highlights a short film on drug-resistant malaria in Myanmar (2/23).

Improving Access To, Preventing Excess Use Of Antibiotics Must Be ‘Global Priority’

CDC’s “Our Global Voices”: The challenge of global antibiotic policy: Improving access and preventing excess Ramanan Laxminarayan, director and senior fellow at the Center for Disease Dynamics, Economics & Policy (CDDEP), discusses a recent CDDEP study published in The Lancet, as well as an accompanying commentary, examining access to antibiotics…

‘Science Speaks’ Examines Recent Publications On Global TB Efforts

Center for Global Health Policy’s “Sciences Speaks”: A progress report, a plan, and a problem without borders … It’s all about following through — we’re reading about confronting tuberculosis Antigone Barton, senior writer and editor of “Science Speaks,” discusses several recently published pieces on tuberculosis, including a personal narrative on…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.